NCT05965427View on ClinicalTrials.gov

Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

May 7, 2025

Study Completion Date

May 7, 2025

Conditions
MonkeypoxHIV Coinfection
Interventions
OTHER

No intervention

Study is retrospective data collection only

Trial Locations (9)

Unknown

Hôpital Bichat Claude Bernard, Paris

Hôpital Pitié-Salpêtrière, Paris

Euroguidelines, Warsaw

Hospital Clinic de Barcelona, Barcelona

Hospital Universitari Germans Trias I Pujol, Barcelona

Hospital Universitari Vall d'Hebron, Barcelona

Hospital San Carlos, Madrid

Hospital Universitario La Paz, Madrid

Chelsea and Westminster Hospital, London

All Listed Sponsors
collaborator

European Commission

OTHER

collaborator

PENTA Foundation

NETWORK

lead

NEAT ID Foundation

OTHER

NCT05965427 - Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV | Biotech Hunter | Biotech Hunter